C2N secures multiple funding deals for blood-based Alzheimer’s test
Longevity Technology,
Diagnostics firm lands more than $20 million in new funding in the past week, with investments from GHR Foundation and ADDF. …
Diagnostics firm lands more than $20 million in new funding in the past week, with investments from GHR Foundation and ADDF. …
A blood test identified Alzheimer’s disease correctly in older adults with about 90% accuracy.
By KIM…
WEDNESDAY, July 31, 2024 (HealthDay News) — The amyloid probability score 2 (APS2) has high diagnostic accuracy for identifying…